|
Bartlett, M S; Queener, S F; Shaw, M M et al. (1997) In vitro and in vivo models of Pneumocystis carinii. J Eukaryot Microbiol 44:51S
|
|
Bartlett, M S; Current, W L; Goheen, M P et al. (1996) Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo. Antimicrob Agents Chemother 40:1811-6
|
|
Bartlett, M S; Shaw, M; Navaran, P et al. (1995) Evaluation of potent inhibitors of dihydrofolate reductase in a culture model for growth of Pneumocystis carinii. Antimicrob Agents Chemother 39:2436-41
|
|
Ittarat, I; Asawamahasakda, W; Bartlett, M S et al. (1995) Effects of atovaquone and other inhibitors on Pneumocystis carinii dihydroorotate dehydrogenase. Antimicrob Agents Chemother 39:325-8
|
|
Queener, S F (1995) New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii. J Med Chem 38:4739-59
|
|
Hong, Y L; Bartlett, M S; Queener, S et al. (1995) Pteroylpolyglutamate synthesis by lung- and culture-derived Pneumocystis carinii. FEMS Microbiol Lett 134:251-4
|
|
Lu, J J; Bartlett, M S; Shaw, M M et al. (1994) Typing of Pneumocystis carinii strains that infect humans based on nucleotide sequence variations of internal transcribed spacers of rRNA genes. J Eukaryot Microbiol 41:102S
|
|
Shaw, M M; Kleyman, T R; Bartlett, M S et al. (1994) Sodium transport inhibitors decrease proliferation of Pneumocystis carinii in short-term culture. J Eukaryot Microbiol 41:110S
|
|
Lu, J J; Bartlett, M S; Shaw, M M et al. (1994) Typing of Pneumocystis carinii strains that infect humans based on nucleotide sequence variations of internal transcribed spacers of rRNA genes. J Clin Microbiol 32:2904-12
|
|
Bartlett, M S; Edlind, T D; Lee, C H et al. (1994) Albendazole inhibits Pneumocystis carinii proliferation in inoculated immunosuppressed mice. Antimicrob Agents Chemother 38:1834-7
|
Showing the most recent 10 out of 39 publications
